Submit Deal

Submit Deal

Cover Image SYMBIOSIS CAPITAL MANAGEMENT LLC

SYMBIOSIS CAPITAL MANAGEMENT LLC

SYMBIOSIS CAPITAL MANAGEMENT LLC

HQ - Bentonville

Summary

SymBiosis Capital Management is a biotechnology-focused investment firm.

Deals Overview

Total Deals12

Valued Deals12

Total Value£ 1.04 B

Avg. Deal Size£ 86 M

Market Context

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2026 Datasite

MergerLinks - SYMBIOSIS CAPITAL MANAGEMENT LLC

Sort

04 Nov 2021|United States|Biotechnology

Target: PLATELETBIO

Bidder: QIMING VENTURE PARTNERS

4 Service Providers

2 Target | 2 Bidder

4 Dealmakers

3 Target | 1 Bidder

£ 55 M

Value

05 Jan 2022|United States|Biotechnology

Target: SALIOGEN THERAPEUTICS

Bidder: FIDELITY MANAGEMENT & RESEARCH COMPANY

6 Service Providers

3 Target | 3 Bidder

8 Dealmakers

4 Target | 4 Bidder

£ 85 M

Value

15 Apr 2021|United States|Biotechnology

Target: BIOSPLICE THERAPEUTICS

Bidder: SANDS CAPITAL

5 Service Providers

1 Target | 4 Bidder

5 Dealmakers

1 Target | 4 Bidder

£ 104 M

Value

05 Jan 2023|United States|Biotechnology

Target: METAGENOMI

Bidder: CATALIO CAPITAL MANAGEMENT

3 Service Providers

1 Target | 2 Bidder

6 Dealmakers

3 Target | 3 Bidder

£ 82 M

Value

05 Jan 2023|United States|Biotechnology

Target: ENSOMA

Bidder: ARIX BIOSCIENCE

19 Service Providers

3 Target | 16 Bidder

19 Dealmakers

3 Target | 16 Bidder

£ 108 M

Value

01 Mar 2024|United States|Biotechnology

Target: FOGPHARMA

Bidder: NEXTECH INVEST

4 Service Providers

2 Target | 2 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 114 M

Value

24 Apr 2024|United States|Biotechnology

Target: ENDEAVOR BIOMEDICINES

Bidder: AYURMAYA CAPITAL

4 Service Providers

3 Target | 1 Bidder

4 Dealmakers

3 Target | 1 Bidder

£ 106 M

Value

09 May 2024|United States|Pharmaceuticals

Target: AARDVARK THERAPEUTICS

Bidder: VICKERS VENTURE PARTNERS

2 Service Providers

1 Target | 1 Bidder

1 Dealmakers

£ 68 M

Value

03 Feb 2025|Australia|Biotechnology

Target: ADVANCELL

Bidder: SYMBIOSIS CAPITAL MANAGEMENT LLC

4 Service Providers

1 Target | 3 Bidder

4 Dealmakers

1 Target | 3 Bidder

£ 90 M

Value

31 Oct 2024|United States|Biotechnology

Target: EVOMMUNE INC

Bidder: SYMBIOSIS CAPITAL MANAGEMENT LLC

4 Service Providers

2 Target | 2 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 88 M

Value

17 Nov 2025|United States|Biotechnology

Target: SOLVE THERAPEUTICS

Bidder: YOSEMITE

4 Service Providers

3 Target | 1 Bidder

4 Dealmakers

3 Target | 1 Bidder

£ 91 M

Value

16 Dec 2025|United States|Biotechnology

Target: AEOVIAN PHARMACEUTICALS INC

Bidder: SYMBIOSIS CAPITAL MANAGEMENT LLC

12 Service Providers

2 Target | 10 Bidder

13 Dealmakers

3 Target | 10 Bidder

£ 41 M

Value